News and Media

Read full article here: https://www.fiercebiotech.com/biotech/ixaka-s-cell-therapy-clears-interim-phase-3-data-review

Read full article here: https://www.thepharmaletter.com/article/ixaka-s-cell-therapy-shows-promise-in-interim-results#:~:text=Private%20UK%2Dbased%20cell%20and,from%20a%20Phase%20III%20trial.&text=The%20product%20is%20produced%20using,enriched%20for%20white%20blood%20cells

Read full article here: https://www.pharmatimes.com/news/positive_interim_data_for_ixakas_lead_multi-cell_therapy_1376392

Read full article here: https://endpts.com/vertex-taps-longtime-commercial-lead-to-fill-two-year-coo-vacancy-nancy-thornberry-set-for-different-role-at-kallyope-with-an-old-friend-from-merck-waiting-in-the-wings/

Read full article here: https://scrip.pharmaintelligence.informa.com/

Read full article here: https://www.biocentury.com/article/633601/rexgenero-rebrands-as-ikaxa-raises-40m-following-gene-therapy-deal

Read full article here: https://endpts.com/a-cardiovascular-cell-therapy-player-grabs-54m-for-a-new-beginning-where-next-gen-car-t-approach-features-prominently/

Read the full article https://www.biopharma-reporter.com/Article/2021/01/18/Rexgenero-has-been-renamed-Ixaka  

Read full article here: https://www.biopharma-reporter.com/

Read full article here: https://www.thepharmaletter.com/article/rexgenero-cleared-to-continue-phase-iii-trial-of-rex-001

Read full article here: https://www.fiercebiotech.com/cro/british-cell-therapy-biotech-rexgenero-nabs-life-science-veteran-as-cmo

Read full article here: https://www.thepharmaletter.com/article/rexgenero-buys-french-car-t-cell-specialist  

Read full article here: https://vascularnews.com/rexgenero-acquires-technology-programme-assets-aratinga/

Watch full interview here:

Read full article here:   https://xconomy.com/national/2020/01/02/rexgenero-ceo-talks-importance-of-dialogue-in-cell-therapy-conversations/